Results 221 to 230 of about 357,434 (340)

Lead nephropathy

, 1976
Richard P. Wedeen
openalex   +1 more source

Hypokalemic Nephropathy [PDF]

Kidney International Reports, 2018
Yalamanchili, Hima Bindu, Calp-Inal, Sumeyye, Zhou, Xin J., Choudhury, Devasmita   +3 more
openaire   +2 more sources

Effect of high‐intensity interval exercise on metformin pharmacokinetics in healthy men, assessed through a population pharmacokinetic model

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Metformin and exercise are first‐line therapies for prediabetes and type 2 diabetes. However, it is unclear whether the combination of metformin and exercise is synergistic or antagonistic. The aim of this study was to investigate the effect of exercise on metformin pharmacokinetics and help clarify the contradictory ...
Stefanos Nikolaidis, Ioannis Kosmidis, Stylianos Papadopoulos, Artemis Lioupi, Marita Gandanidou, Helen Gika, Aristides Dokoumetzidis, Georgios Theodoridis, Vassilis Mougios   +8 more
wiley   +1 more source

Is Contrast-Enhanced Imaging in the Emergency Department a Risk Factor for Contrast-Associated Acute Kidney Injury? [PDF]

Int J Gen Med
Üğe LA, Üzüm Y, Üğe M, Soypacaci Z.   +3 more
europepmc   +1 more source

Immunologic studies in IgA nephropathy [PDF]

, 1980
Andrew J. Woodroffe, Alan A. Gormly, Peter McKenzie, Andrew Wootton, Aileen J. Thompson, A. E. Seymour, A. R. Clarkson   +6 more
openalex   +1 more source

Rituximab or cyclosporine in the treatment of membranous nephropathy [PDF]

, 2019
al., et, Li, Tingting
core   +1 more source

Deep learning‐enhanced 3D imaging unveils semaglutide impact on cardiac fibrosis

British Journal of Pharmacology, EarlyView.
Background and Purpose Myocardial fibrosis (MF), a hallmark of structural cardiac remodelling, drives disease progression across most forms of heart failure and plays a central role in heart failure with preserved ejection fraction (HFpEF). Despite its clinical relevance, effective treatments remain scarce.
Sheyla Barrado‐Ballestero, Sarah Torp Yttergren, Max Hahn, Marie Biviano Rosenkilde, Ditte Marie Jensen, Michael Christensen, Louise Thisted, Heidi Lindgreen Holmberg, Geoffrey Teixeira, Tor Biering‐Sørensen, Casper Gravesen Salinas, Urmas Roostalu   +11 more
wiley   +1 more source

Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study. [PDF]

Front Pharmacol
Tao L, Zhang X, Niu X, Liu G, Jiao X, Shao F, Cao H.   +6 more
europepmc   +1 more source

Diagnostic Yield and Clinical Impact of a Small Genetic Panel for Kidney Disease: A Multicenter, Retrospective European Study

Clinical Genetics, EarlyView.
In a multicenter study of 692 patients with kidney disease, a 44‐gene panel achieved a 36% diagnostic yield. The 36% yield was not significantly lower than with larger panels or whole‐exome sequencing. A post hoc machine‐learning model identified key predictors to stratify patients into four risk bins (11%–74% yield), enabling more cost‐effective ...
Silvia Giovanella, Antonio Miguel Poyatos‐Andújar, Maria Mar Aguila Garcia, Almudena Avila‐Fernandez, Ana Bustamante‐Aragonés, Carmen Ayuso, Antonio Percesepe, Davide Martorana, Maria Ferri, Alessandra Terracciano, Laura Massella, Johanna Chester, Francesca Testa, Giulia Ligabue, Marco Ferrarini, Dino Gibertoni, Gaetano Alfano, Elena Tenedini, Lucia Artuso, Marco Marino, Olga Calabrese, Enrico Tagliafico, Riccardo Magistroni   +22 more
wiley   +1 more source

Microvascular Outcomes of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Type 2 Diabetes: A Systematic Review of Retinopathy and Nephropathy Evidence. [PDF]

Cureus
Arif A, Lama S, Singla B, Singla S, Kumawat S, Tharwani A, Usman M, Khalid H, Kanukollu VMR, Ekomwereren O, Khan S.   +10 more
europepmc   +1 more source